Your browser doesn't support javascript.
loading
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor.
Cerva, C; Colagrossi, L; Maffongelli, G; Salpini, R; Di Carlo, D; Malagnino, V; Battisti, A; Ricciardi, A; Pollicita, M; Bianchi, A; Picardi, A; Cudillo, L; Cerretti, R; De Angelis, G; Cantonetti, M; Andreoni, M; Perno, C F; Arcese, W; Svicher, V; Sarmati, L.
Afiliação
  • Cerva C; Clinical Infectious Disease, Department of System Medicine, Tor Vergata University, Rome, Italy.
  • Colagrossi L; Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, Italy.
  • Maffongelli G; Clinical Infectious Disease, Department of System Medicine, Tor Vergata University, Rome, Italy.
  • Salpini R; Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, Italy.
  • Di Carlo D; Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, Italy.
  • Malagnino V; Clinical Infectious Disease, Department of System Medicine, Tor Vergata University, Rome, Italy.
  • Battisti A; Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, Italy.
  • Ricciardi A; Clinical Infectious Disease, Department of System Medicine, Tor Vergata University, Rome, Italy.
  • Pollicita M; Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, Italy.
  • Bianchi A; Clinical Infectious Disease, Department of System Medicine, Tor Vergata University, Rome, Italy.
  • Picardi A; Department of Hematology, Stem Cell Transplant Unit, Tor Vergata University, Rome, Italy.
  • Cudillo L; Department of Hematology, Stem Cell Transplant Unit, Tor Vergata University, Rome, Italy.
  • Cerretti R; Department of Hematology, Stem Cell Transplant Unit, Tor Vergata University, Rome, Italy.
  • De Angelis G; Department of Hematology, Stem Cell Transplant Unit, Tor Vergata University, Rome, Italy.
  • Cantonetti M; Department of Hematology, Stem Cell Transplant Unit, Tor Vergata University, Rome, Italy.
  • Andreoni M; Clinical Infectious Disease, Department of System Medicine, Tor Vergata University, Rome, Italy.
  • Perno CF; Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, Italy.
  • Arcese W; Department of Hematology, Stem Cell Transplant Unit, Tor Vergata University, Rome, Italy.
  • Svicher V; Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, Italy.
  • Sarmati L; Clinical Infectious Disease, Department of System Medicine, Tor Vergata University, Rome, Italy. Electronic address: sarmati@med.uniroma2.it.
Clin Microbiol Infect ; 22(11): 946.e1-946.e8, 2016 Nov.
Article em En | MEDLINE | ID: mdl-27475741
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Hepatite B / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Lamivudina / Hepatite B Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Microbiol Infect Assunto da revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Hepatite B / Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Lamivudina / Hepatite B Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Microbiol Infect Assunto da revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Itália